Members |
acceptabilityId |
ydre scleraoverflade som helhed |
Preferred (foundation metadata concept) |
ydre segment af retinal fotoreceptor |
Preferred (foundation metadata concept) |
ydre skorpelag af sten |
Preferred (foundation metadata concept) |
ydre sporehinde |
Preferred (foundation metadata concept) |
ydre øre |
Preferred (foundation metadata concept) |
ydre øre som helhed |
Preferred (foundation metadata concept) |
ydre øregangs indre kartilaginøse del som helhed |
Preferred (foundation metadata concept) |
ydre øregangs insirura cartilaginis som helhed |
Preferred (foundation metadata concept) |
ydre øregangs mellemste kartilaginøse del som helhed |
Preferred (foundation metadata concept) |
ydre øregangs ydre kartilaginøse del som helhed |
Preferred (foundation metadata concept) |
ydre øres subkutane væv som helhed |
Preferred (foundation metadata concept) |
yellow nail-syndrom |
Preferred (foundation metadata concept) |
yi |
Preferred (foundation metadata concept) |
yi, Sichuan |
Preferred (foundation metadata concept) |
ylang-ylang-olie |
Preferred (foundation metadata concept) |
ylang-ylang-olie |
Preferred (foundation metadata concept) |
yngre barn |
Preferred (foundation metadata concept) |
yngre barnepige |
Preferred (foundation metadata concept) |
yngre bror |
Preferred (foundation metadata concept) |
yngre søskende |
Preferred (foundation metadata concept) |
yngre søster |
Preferred (foundation metadata concept) |
yngste datter |
Preferred (foundation metadata concept) |
yngste søn |
Preferred (foundation metadata concept) |
yoghurt-rasttest |
Preferred (foundation metadata concept) |
yohimbin |
Preferred (foundation metadata concept) |
yohimbin |
Preferred (foundation metadata concept) |
yohimbin + pemolin + methyltestosteron 5 mg/10 mg/5 mg kapsel |
Preferred (foundation metadata concept) |
yohimbin/pemolin/methyltestosteron |
Preferred (foundation metadata concept) |
yohimbinhydrochlorid |
Preferred (foundation metadata concept) |
yohimbinhydrochlorid 5 mg/5 ml opløsning |
Preferred (foundation metadata concept) |
yohimbinhydrochlorid 5,4 mg tablet |
Preferred (foundation metadata concept) |
yoruba |
Preferred (foundation metadata concept) |
yoruba-religion |
Preferred (foundation metadata concept) |
ypsilon |
Preferred (foundation metadata concept) |
yttrium-90 |
Preferred (foundation metadata concept) |
yttrium-90-mikrosfærer |
Preferred (foundation metadata concept) |
yttrium-chlorid [90Y] prækursoropløsning |
Preferred (foundation metadata concept) |
yttrium[90Y]-silikat injektionsvæske |
Preferred (foundation metadata concept) |
yttriumradioisotop |
Preferred (foundation metadata concept) |
yucatekisk |
Preferred (foundation metadata concept) |
yuma |
Preferred (foundation metadata concept) |
yumasprog |
Preferred (foundation metadata concept) |
z |
Preferred (foundation metadata concept) |
z-score |
Preferred (foundation metadata concept) |
zafirlukast |
Preferred (foundation metadata concept) |
zafirlukast |
Preferred (foundation metadata concept) |
zafirlukast 10 mg tablet |
Preferred (foundation metadata concept) |
zafirlukast 20 mg tablet |
Preferred (foundation metadata concept) |
zalcitabin |
Preferred (foundation metadata concept) |
zalcitabin 375 µg tablet |
Preferred (foundation metadata concept) |
zalcitabin 750 µg tablet |
Preferred (foundation metadata concept) |
zaleplon |
Preferred (foundation metadata concept) |
zaleplon |
Preferred (foundation metadata concept) |
zaleplon 10 mg kapsel |
Preferred (foundation metadata concept) |
zaleplon 5 mg kapsel |
Preferred (foundation metadata concept) |
zanamivir |
Preferred (foundation metadata concept) |
zanamivir |
Preferred (foundation metadata concept) |
zanamivir 5 mg/blister plader + diskhaler |
Preferred (foundation metadata concept) |
zanamivirresistent virus påvist |
Preferred (foundation metadata concept) |
zande |
Preferred (foundation metadata concept) |
zanolimumab |
Preferred (foundation metadata concept) |
zapotec |
Preferred (foundation metadata concept) |
zarathustrier |
Preferred (foundation metadata concept) |
zebralegemer |
Preferred (foundation metadata concept) |
zenbuddhisme |
Preferred (foundation metadata concept) |
zenbuddhist |
Preferred (foundation metadata concept) |
zeranol |
Preferred (foundation metadata concept) |
zeranolpræparat |
Preferred (foundation metadata concept) |
zeta |
Preferred (foundation metadata concept) |
zeta-sænkningsreaktion |
Preferred (foundation metadata concept) |
zhuang |
Preferred (foundation metadata concept) |
ziconotid |
Preferred (foundation metadata concept) |
ziconotid |
Preferred (foundation metadata concept) |
ziconotid 100 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml |
Preferred (foundation metadata concept) |
ziconotid 100 µg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
Preferred (foundation metadata concept) |
ziconotid 100 µg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
Preferred (foundation metadata concept) |
ziconotid 25 µg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
Preferred (foundation metadata concept) |
ziconotidacetat |
Preferred (foundation metadata concept) |
zidovudin |
Preferred (foundation metadata concept) |
zidovudin 10 mg/ml infusionsvæske, opløsning, hætteglas a 20 ml |
Preferred (foundation metadata concept) |
zidovudin 10 mg/ml opløsning |
Preferred (foundation metadata concept) |
zidovudin 100 mg kapsel |
Preferred (foundation metadata concept) |
zidovudin 200 mg/20 ml opløsning |
Preferred (foundation metadata concept) |
zidovudin 250 mg kapsel |
Preferred (foundation metadata concept) |
zidovudin 300 mg tablet |
Preferred (foundation metadata concept) |
zidovudin 50 mg/5 ml syrup |
Preferred (foundation metadata concept) |
zig-zag-konfiguration af cristae i mitokondrie |
Preferred (foundation metadata concept) |
zileuton |
Preferred (foundation metadata concept) |
zileuton |
Preferred (foundation metadata concept) |
zileuton 600 mg depottablet |
Preferred (foundation metadata concept) |
zileuton 600 mg tablet |
Preferred (foundation metadata concept) |
zineb |
Preferred (foundation metadata concept) |
zineb |
Preferred (foundation metadata concept) |
zink + salicylsyre-pasta i halv styrke |
Preferred (foundation metadata concept) |
zink til oral anvendelse |
Preferred (foundation metadata concept) |
zink til parenteral anvendelse |
Preferred (foundation metadata concept) |
zink til topikal anvendelse |
Preferred (foundation metadata concept) |
zinkacetat |
Preferred (foundation metadata concept) |
zinkacetatdihydrat |
Preferred (foundation metadata concept) |
zinkacetatdihydrat |
Preferred (foundation metadata concept) |
zinkarsenat |
Preferred (foundation metadata concept) |